QXO, Inc.
QXO
$15.95
-4.49%
QXO, Inc. is a North American distributor of building products, operating within the vast industrial distribution sector. The company is positioning itself as a tech-enabled leader with an ambitious plan to consolidate the fragmented, approximately $800 billion building products distribution industry. The current investor narrative is dominated by its transformative, large-scale acquisition strategy, most notably the recently announced $17 billion deal to acquire TopBuild, which aims to create a scaled industry leader but has introduced significant execution risk and near-term dilution concerns, driving intense debate around the stock's valuation and integration prospects.…
QXO
QXO, Inc.
$15.95
Related headlines
Investment Opinion: Should I buy QXO Today?
Rating: Hold. The core thesis is that QXO presents a high-risk, high-reward speculative turnaround story where the potential long-term payoff from successful consolidation is currently overshadowed by severe near-term execution risks and profitability concerns, warranting a cautious stance despite covering analysts' bullish ratings.
Supporting evidence for this Hold rating includes: 1) The stock trades at a moderate PS ratio of 1.73, which is not demanding for a growth story but justified by negative margins. 2) Revenue growth is explosive at 147.8% YoY, but sequential volatility (Q3 to Q4 decline) questions organic stability. 3) Profitability metrics are deeply negative (Net Margin: -4.08%, Operating Margin: -3.58%), a fundamental red flag. 4) While analyst sentiment is nominally positive (3 Buy/Outperform ratings), the lack of a consensus price target and low coverage count undermines the strength of this signal, reflecting high uncertainty.
The two biggest risks that could invalidate a neutral stance are a further deterioration in gross margins below the current 24.15% and a failure to show a credible path to positive operating income post-TopBuild integration. This Hold would upgrade to a Buy only on concrete evidence of successful integration, such as two consecutive quarters of expanding operating margins and stable or growing sequential revenue. It would downgrade to a Sell on a break below the $15.5 support level on high volume or a significant downward revision to forward revenue estimates. Relative to its own risky profile and lack of profits, the stock is fairly valued, as the moderate sales multiple accurately reflects the binary bet between transformative success and costly failure.
Sign up to view all
QXO 12-Month Price Forecast
The outlook for QXO is highly uncertain and binary, with the probability-weighted base case pointing to continued volatility and sideways trading. The recent price action is a powerful signal that near-term risks dominate. While the strategic vision is grand, the company must first prove it can operate profitably at its new scale. The AI stance is neutral, as the current price fairly balances the transformative upside against the very real possibility of further value destruction. Confidence is medium because the key variables—integration success and margin trajectory—are currently unobservable. This stance would upgrade to bullish on two consecutive quarters of expanding operating margins and would downgrade to bearish on a confirmed break below the $15.5 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QXO, Inc.'s 12-month outlook, with a consensus price target around $20.73 and implied upside of +30.0% versus the current price.
Average Target
$20.73
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$13 - $21
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, indicating this is a stock with lower institutional following which can lead to higher volatility and less efficient price discovery. The available data provides consensus revenue and EPS estimates but does not include a consensus price target, Buy/Hold/Sell distribution, or a target price range, making a quantitative assessment of analyst sentiment impossible; the recent institutional ratings from Oppenheimer, Citigroup, and Truist Securities all maintain 'Buy' or 'Outperform' ratings, suggesting the covering firms are bullish on the long-term strategic vision despite the recent severe price decline. Without explicit price targets, the signal strength and the assumptions behind high and low targets cannot be determined; the maintenance of positive ratings by key firms in the face of a crashing stock price could be interpreted either as a strong conviction in the long-term story or a lagging indicator, and the lack of a broad analyst consensus underscores the high uncertainty and binary outcome nature of the investment thesis centered on massive M&A integration.
Bulls vs Bears: QXO Investment Factors
The bull and bear cases for QXO present a stark, binary investment thesis centered on the success or failure of its transformative, acquisition-driven growth strategy. The bull side is anchored by the sheer scale of the TopBuild deal, explosive revenue growth, and maintained analyst buy ratings, suggesting a long-term vision that could justify the current pain. The bear side is overwhelmingly supported by the severe price collapse, deep and persistent unprofitability, and the monumental execution risk of integrating a $17 billion acquisition. Currently, the bear evidence is stronger, as the market is voting decisively on the near-term risks, with the stock's technical breakdown and negative margins providing concrete, present-tense concerns that outweigh future potential. The single most important tension is whether QXO can transition from a capital-intensive, loss-making consolidator to a profitable, scaled operator—the resolution of which will determine if the stock is a deep-value turnaround or a value trap.
Bullish
- Transformative $17B TopBuild Acquisition: The recently announced $17 billion acquisition of TopBuild is a game-changer, aiming to create a scaled leader in the $800 billion building products distribution industry. This deal is central to QXO's strategy to reach nearly $50 billion in annual revenue within a decade, offering a massive potential for market consolidation and synergy capture if executed successfully.
- Explosive Revenue Growth Trajectory: Q4 2025 revenue of $2.19 billion represents a staggering 147.8% year-over-year growth, demonstrating the immediate scale impact of its acquisition strategy. This explosive growth, albeit inorganic, positions the company on a path towards its ambitious long-term revenue targets, fundamentally altering its market position.
- Strong Analyst Conviction Amid Selloff: Despite a 29.67% one-month price decline, the three covering analysts from Oppenheimer, Citigroup, and Truist all maintain 'Buy' or 'Outperform' ratings. This suggests institutional conviction in the long-term strategic vision, viewing the current weakness as a potential entry point rather than a fundamental breakdown.
- Healthy Liquidity and Positive FCF: The company maintains a strong current ratio of 3.58 and generated positive trailing-twelve-month free cash flow of $183.2 million. This provides a crucial financial cushion to navigate the integration of large acquisitions and service potential debt from the TopBuild deal.
Bearish
- Severe Profitability and Margin Issues: The company is deeply unprofitable, with a Q4 2025 net loss of $90.3 million (EPS -$0.21) and negative operating margins of -3.18%. Gross margins of 24.15% are thin for a distributor, raising serious questions about the underlying economics and integration efficiency of its acquired businesses.
- Extreme Price Collapse and Technical Breakdown: The stock is in a severe downtrend, down 39.67% over three months and 29.67% over one month, underperforming the S&P 500 by 48.09 and 35.27 percentage points, respectively. Trading at $16.33, just 5.4% above its 52-week low of $15.5, signals extreme selling pressure and a complete breakdown of investor confidence.
- Massive Execution and Integration Risk: The core investment thesis hinges on successfully integrating the massive, debt-funded $17 billion TopBuild acquisition. The company's history shows volatile sequential revenue (down from $2.73B in Q3 to $2.19B in Q4) and deeply negative EBITDA in Q2 2025, highlighting the immense challenge of managing this rapid, acquisition-driven scale.
- High Volatility and Short Interest: With a beta of 2.37, the stock is 137% more volatile than the market, and a short ratio of 6.48 indicates intense skepticism. This combination creates a high-risk environment prone to sharp, sentiment-driven moves, amplifying downside risk during periods of negative news or execution missteps.
QXO Technical Analysis
The prevailing price trend is a sharp and sustained downtrend from recent highs, with the stock down 39.67% over the past three months and 29.67% over the past month, significantly underperforming the S&P 500's gains of 8.42% and 5.6% over the same periods, respectively. Currently trading at $16.33, the price sits just 5.4% above its 52-week low of $15.5, positioning it near the absolute bottom of its annual range, which suggests either a deep value opportunity or a stock in fundamental distress, having failed to hold gains from its 52-week high of $27.61. Recent momentum is decisively negative and accelerating the longer-term decline, with the 1-month loss of 29.67% far exceeding the 3-month loss of 39.67%, indicating severe selling pressure and a breakdown from previous consolidation levels; this is corroborated by a staggering -35.27 relative strength versus the market over one month, signaling extreme weakness. Key technical support is firmly established at the 52-week low of $15.5, while resistance lies at the recent breakdown level around $27.61; a sustained break below $15.5 would signal a continuation of the downtrend, whereas a recovery above the $20 level is needed to suggest stabilization. The stock's beta of 2.37 indicates it is 137% more volatile than the broader market, which, combined with the recent price collapse and a short ratio of 6.48, points to exceptionally high risk and potential for sharp, sentiment-driven moves in either direction.
Beta
2.37
2.37x market volatility
Max Drawdown
-41.1%
Largest decline past year
52-Week Range
$16-$28
Price range past year
Annual Return
-8.9%
Cumulative gain past year
| Period | QXO Return | S&P 500 |
|---|---|---|
| 1m | -36.2% | +3.3% |
| 3m | -40.1% | +6.9% |
| 6m | -0.9% | +12.4% |
| 1y | -8.9% | +23.4% |
| ytd | -19.1% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QXO Fundamental Analysis
Revenue trajectory shows explosive but acquisition-driven growth, with Q4 2025 revenue of $2.19 billion representing a staggering 147.8% year-over-year increase; however, examining sequential quarters reveals volatility, with revenue dipping from $2.73 billion in Q3 2025, indicating the core organic growth story is heavily obscured by large-scale M&A activity and integration challenges. The company is deeply unprofitable on a net income basis, posting a Q4 2025 net loss of $90.3 million and an EPS of -$0.21, with gross margins of 24.15% that are thin for a distributor and operating margins deeply negative at -3.18%, reflecting significant integration costs and potential inefficiencies at its newly acquired scale. Financial health is a critical concern: while the company generated positive free cash flow of $183.2 million (TTM) and maintains a strong current ratio of 3.58, its balance sheet has been transformed by the acquisition spree, evidenced by a net cash used in investing activities of $10.6 billion in Q2 2025 for acquisitions; the debt-to-equity ratio of 0.46 appears manageable but likely does not yet reflect the full financing of the massive TopBuild deal, raising questions about future leverage and cash flow sustainability for debt service.
Quarterly Revenue
$2.2B
2025-12
Revenue YoY Growth
+147.81%
YoY Comparison
Gross Margin
+0.24%
Latest Quarter
Free Cash Flow
$183199999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QXO Overvalued?
Given the company's negative net income and EPS of -$0.0236, the primary valuation metric selected is the Price-to-Sales (PS) ratio. QXO trades at a trailing PS ratio of 1.73, while its forward valuation is not explicitly provided but can be inferred against analyst revenue estimates; the EV/Sales ratio of 1.7 provides a similar enterprise-level view, suggesting the market is valuing the post-acquisition sales base at a moderate multiple. Compared to industry averages, specific sector PS data is not available in the provided dataset, making a precise peer comparison impossible; however, a PS ratio around 1.7x for a low-margin, acquisitive distributor could be considered reasonable if future margin expansion and synergy capture are credibly projected, but the current negative margins warrant a significant discount. Historically, the stock's own valuation has undergone a radical transformation: earlier quarterly data shows PS ratios in the hundreds when the company was a micro-cap shell, but more recent post-acquisition figures (e.g., 0.05 in Q4 2025) suggest the current multiple of 1.73 represents a substantial re-rating higher as the market prices in the transformative, yet risky, growth-by-acquisition strategy and its attendant execution risks.
PE
-42.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -795413x~61919x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
38.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on profitability and leverage. The company is burning cash at the operating level, with a Q4 2025 net loss of $90.3 million and an operating margin of -3.18%. While TTM free cash flow is positive at $183.2 million, this was likely generated prior to the massive acquisition spree, including $10.6 billion in net cash used for investing in Q2 2025. The debt-to-equity ratio of 0.46 appears manageable but does not yet reflect the full financing of the $17 billion TopBuild deal, raising significant future risks around debt service, interest expense (which was $36.4 million in Q4), and the sustainability of its cash flow.
Market & Competitive Risks are amplified by QXO's valuation and market positioning. The stock's extreme beta of 2.37 makes it highly sensitive to broader market downturns and risk-off sentiment, which could compress its already moderate PS ratio of 1.73 further. The ambitious plan to consolidate a fragmented industry invites competitive responses from established players and private equity. Furthermore, the company's narrative is now inextricably linked to the success of a single, massive acquisition (TopBuild), creating a binary outcome that magnifies stock-specific risk and reduces the margin for error in execution.
Worst-Case Scenario involves a failure to integrate TopBuild successfully, leading to sustained losses, covenant breaches on new debt, and a loss of investor confidence that triggers a liquidity crisis. In this scenario, the stock could break decisively below its key technical support at the 52-week low of $15.5. Given the stock's recent 39.67% three-month drawdown and high volatility, a realistic downside could see it re-test levels 35-40% below the current $16.33 price, potentially falling into the $9-$11 range, as the market prices in a failed consolidation strategy and a prolonged period of value destruction.
FAQ
The key risks are, in order of severity: 1) Execution/Integration Risk: The monumental challenge of profitably integrating the $17 billion TopBuild acquisition, as evidenced by current negative operating margins of -3.18%. 2) Financial Risk: The potential for increased leverage and debt service burdens post-acquisition, alongside persistent cash burn. 3) Market Risk: Extreme stock volatility with a beta of 2.37, making it highly sensitive to market downturns. 4) Sentiment Risk: High short interest (short ratio 6.48) and low analyst coverage (3 firms) can lead to exaggerated price moves on news, both positive and negative.
The 12-month forecast is highly uncertain, with three distinct scenarios. The base case (50% probability) sees the stock trading between $18 and $22 as integration challenges persist but the company meets revenue targets. The bull case (25% probability) could drive the stock to $27-$32 on successful margin expansion. The bear case (25% probability) risks a drop to $10-$15.5 if integration fails. The most likely outcome is the base case of volatile, range-bound trading, as the company is in a 'show me' period where proving its business model is more important than near-term price targets.
Based on traditional metrics, QXO is fairly valued given its current state. With negative earnings, the primary metric is Price-to-Sales (PS) at 1.73x, which is a moderate multiple for a distributor. This multiple is not cheap for an unprofitable company, nor is it excessively high for one pursuing explosive growth via acquisition. The valuation implies the market is pricing in significant execution risk and is withholding a premium until profitability emerges. Compared to its own history of extreme multiples during its micro-cap phase, the current valuation reflects its new, scaled-but-unproven reality.
QXO is not a good buy for most investors due to its exceptionally high risk profile. It is a speculative bet on a complex, debt-funded acquisition strategy (the $17B TopBuild deal) with the stock down nearly 40% in three months and the company posting a Q4 net loss of $90.3 million. For a very risk-tolerant investor with a long-term view who believes deeply in the consolidation thesis and can withstand further volatility, the current price near its 52-week low might represent an entry point, but it should be considered a high-conviction, small-position speculation, not a core holding.
QXO is strictly a long-term investment for those who buy the multi-year consolidation story, with a suggested minimum holding period of 3-5 years to see the TopBuild integration through. It is wholly unsuitable for short-term trading or income investors due to its extreme volatility (beta 2.37), lack of dividend (yield 0.89%), and negative earnings visibility. The investment thesis is based on a decade-long plan to reach $50 billion in revenue; attempting to trade around this narrative in the short term is exceptionally risky given the stock's propensity for sharp, sentiment-driven moves.